Multiplex Assays Market research report by Delvens focuses on primary sections such as – market segments, market outlook, competitive landscape, and company profiles. The segments provide details in terms of various perspectives such as end-use industry, product or service type, and any other relevant segmentation as per the market’s current scenario which includes various aspects to perform further marketing activity.
The global Multiplex Assays Market size is projected to reach a CAGR of 10.3% from 2023-2030.
Get Free Sample Report: https://www.delvens.com/get-free-sample/multiplex-assays-market
The prominent players in Multiplex Assays Market are
· Luminex Corporation
· Thermo Fisher Scientific Inc.
· Illumina Inc.
· Bio-Rad Laboratories Inc.
· QIAGEN N.V.
· Becton, Dickinson and Company
· Abcam PLC
· Seegene Inc.
· Meso Scale Diagnostics LLC
· Randox Laboratories Ltd.
· DIASORIN S.P.A.
· MERCK KGAA
· AGILENT TECHNOLOGIES, INC.
· QUANTERIX
· BIO-TECHNE
· OLINK
· SEEGENE INC.
· SIEMENS HEALTHINEERS AG
· PERKINELMER INC.
· SHIMADZU CORPORATION
· PROMEGA CORPORATION
· ENZO BIOCHEM INC.
· CAYMAN CHEMICAL
· BOSTER BIOLOGICAL TECHNOLOGY
· ANTIGENIX AMERICA, INC.
· QUANSYS BIOSCIENCES INC.
· RAYBIOTECH LIFE, INC.
Key Findings of Multiplex Assays Market:
· The product and services segment are further segmented into Consumables, Instruments, and Software and Services. The consumables segment is anticipated to hold the largest share during the forecast period. This can be attributed to the recurring purchase of assays and reagents for increasing research applications.
· The type segment is further segmented into Protein Multiplex Assays, Nucleic Acid Multiplex Assays, and Cell-Based Multiplex Assays. The protein-based multiplex assay segment is expected to account for the largest share of the global multiplex assay market. This large share can be attributed to the increasing focus on proteomics studies for biomarker research and clinical diagnostics.
· The technology segment is further segmented into Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, and Other Technologies. The flow cytometry segment is expected to account for the largest share of the global multiplex assay market. The large share can be attributed to the wide applications of flow cytometry in the detection and measurement of protein expression, RNA, and cell health status (cell viability & toxicity) alongside the characterization and identification of various cell types.
· The application segment is further segmented into Research & Development and Clinical diagnostics. the research & development segment is expected to account for the largest share of the global multiplex assays market. This large share can be attributed to the wide applications of multiplex assay technologies in research & development functions.
· The end-user segment is further segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, and Other End Users. The pharmaceutical & biotechnology companies’ segment is expected to account for the largest share of the global multiplex assays market. This large share can be attributed to the increasing adoption of multiplex assays in drug discovery and development by pharmaceuticals and the growing focus of biotechnology companies on developing biosimilars and monoclonal antibodies.
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/multiplex-assays-market
Regional Analysis
North America to Dominate the Market
· North America was the largest regional market in terms of revenue. The increasing prevalence of chronic diseases, such as cancer, the aging population, growing demand for targeted and personalized medicine, and favourable government initiatives are the primary factors behind the large market size. The growth can also be attributed to the presence of sophisticated diagnostics laboratories and a high acceptance rate of novel assay technologies.
· Asia Pacific is expected to register the highest CAGR in the market during the forecast period. Growth in the APAC region is largely driven by the increasing R&D investment by the government and increasing infrastructural development in the region.
Recent Developments
· In February 2022, Adobe added mobile marketing personalization capabilities to journey optimizer that enables users to better engage their customers on smartphones. The seven capabilities include Message Designer, with which users can design personalized email, push notifications and in-app messages from one console for customers on mobile devices; personalized app experiences, which consider app usage and other factors; and unified customer profiles, which drive analytics in workflows.
· In December 2021, with the Dynamics 365 Marketing December 2021 update, the user can create journey branches based on any attribute, track unsubscribed users in real-time marketing insights, and manage Microsoft Teams meeting options from the Dynamics 365 Marketing app. The update also includes general performance upgrades and bug fixes.
Access Full Report: https://www.delvens.com/report/multiplex-assays-market
In addition to the market data for Multiplex Assays Market, Delvens offers a client-centric report customized according to the company’s specific demand and requirement.
Reasons to Acquire
· Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors.
· Gain authentic and granular data access for Multiplex Assays Market so as to understand the trends and the factors involved behind changing market situations.
· Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
· In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.
More Reports From Delvens:
Nerve Repair & Regeneration Market
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
Unit No. 01, 3rd Floor, Plot No. 56, Block B
Sector 2 Noida, Near Noida Sector 15 Metro Station 201301, IN
+44 20 3290 6466
+0120- 4903958
